ArticleHuman vaccines & immunotherapeutics2021
Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.
Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- Influenza, COVID-19, and pneumococcal vaccination status among adults in Türkiye.Turkish journal of medical sciences · 2026Article
- Knowledge, attitudes and practices towards immunization among adult population in a tertiary care hospital-exploratory survey.Clinical and experimental vaccine research · 2026Article
- Cost-effectiveness and public health impact of influenza vaccination strategies for Chinese patients with rheumatoid arthritis.Human vaccines & immunotherapeutics · 2025Article
- Article
- Article
- Sociocultural and moral narratives influencing the decision to vaccinate among rheumatic disease patients: a qualitative study.Clinical rheumatology · 2023Article
- Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review.Vaccines · 2023Review
- Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review.RMD open · 2022Article
- Explorative study regarding influenza vaccine hesitancy among HIV-infected patients.Human vaccines & immunotherapeutics · 2022Article
- Factors associated with influenza vaccination coverage and willingness in the elderly with chronic diseases in Shenzhen, China.Human vaccines & immunotherapeutics · 2022Article
- COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).The Journal of rheumatology · 2022Article
- Influenza Vaccine Hesitancy and Its Determinants Among Rheumatology Patients.ACR open rheumatology · 2022Article
- Understanding the Attitudes and Willingness of Adult Chinese Patients with Rheumatic Diseases Towards COVID-19 Vaccination.Risk management and healthcare policy · 2022Article
- A survey of systemic lupus erythematosus patients' attitudes toward influenza and pneumococcal vaccination in Southwest China.Frontiers in public health · 2022Article
- COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases.Human vaccines & immunotherapeutics · 2021Article
- SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.Human vaccines & immunotherapeutics · 2021Article
- Exploring and Monitoring the Reasons for Hesitation with COVID-19 Vaccine Based on Social-Platform Text and Classification Algorithms.Healthcare (Basel, Switzerland) · 2021Article
- Influenza Vaccination in Psoriatic Patients-Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso).Vaccines · 2021Article
- Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases.The Lancet. Rheumatology · 2021Article
- Vaccination in rheumatic disease patients: results of a pilot quality improvement program.Reumatologia · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with rheumatic diseases (RD) have a higher risk of morbidity and mortality from vaccine-preventable infections attributed to disease activity, comorbidities, immunosuppressive therapy, and other factors. Vaccines are one of the safest and most effective public health interventions. The aim of this study was to investigate knowledge and attitudes about influenza vaccination as factors influencing vaccine uptake and hesitancy in a population with RD. A descriptive cross-sectional study was designed. A self-administered questionnaire surveyed age, RD diagnosis, ten questions about the uptake, safety and efficacy of influenza vaccine, knowledge of cost-free availability, and the relationship between influenza vaccination and RD. A total of 223 questionnaires were filled; 79.8% of patients were vaccinated for influenza at least once. Uptake by diagnosis was 80.3% in rheumatoid arthritis, 76.2% in osteoarthritis, 86.7% in lupus, 73.9% in other auto-immune diseases (AID), and 60% in other non-AID; 83.9% of patients considered influenza vaccine as safe and effective. From those who had never been vaccinated, 26.7% of patients did not consider influenza vaccine safe and effective vs. 13.5% among patients who had been vaccinated (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.